Prevalence of neuropathic pain in one year survivors after intensive care admissio

Completed

• Conditions: Nerve pain; 10034606

• Registration Number: NL-OMON45349
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

1. Patient was 18 years or older at the time of ICU admission.
2. Length of stay in the ICU > 48 hours.
3. Recent address and vital (survivorship) status confirmed by follow-up survey.
4. Spoken informed consent from the patient is obtained during a telephone call
Subsequent written informed consent from patient will be obtained during the home visit (before performing measurements).

Exclusion Criteria

Patients who are not competent to provide informed consent (i.e. patients with severe cognitive dysfunction).

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the prevalence of neuropathic pain in the study<br /><br>population as measured with the Douleur Neuropathique 4 (DN4) questionnaire.<br /><br>Besides 7 questions, this questionnaires contains also 3 items of short<br /><br>physical examination of the painful area. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable. </p><br>